Saunders J
Medicinal Chemistry II, Glaxo Group Research, Greenford, Middlesex, UK.
Drug Des Discov. 1993;9(3-4):213-20.
A ligand binding model for receptors linked to G-protein activation proposes that antagonists and agonists are able to distinguish two different binding sites on the receptor.